Tg(Lck-AVEN)1Zrng
Transgene Detail
|
|
| Symbol: |
Tg(Lck-AVEN)1Zrng |
| Name: |
transgene insertion 1, Martin Zoernig |
| MGI ID: |
MGI:5317419 |
| Synonyms: |
Tg(Lck-Aven) |
| Transgene: |
Tg(Lck-AVEN)1Zrng Location: unknown
|
| Alliance: |
Tg(Lck-AVEN)1Zrng page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Tg(Lck-AVEN)1Zrng expresses
1 gene
Transgene expresses:
| Organism |
Expressed Gene |
Homolog in Mouse |
Note |
| human |
AVEN (57099) |
|
|
|
| |
|
Mutation details: This transgene contains a full-length cDNA encoding human caspase activation inhibitor (AVEN) inserted into the p1017 expression vector, which contains a 3.2 kb fragment of the mouse lymphocyte protein tyrosine kinase (Lck) gene that includes its thymocyte-specific proximal promoter through nucleotide +37 (relative to the transcription initiation site) upstream of the nearly full-length human growth hormone (GH1) gene; the insertion site is in the truncated first exon of GH1, which encodes the 5' UTR.
(J:82809, J:132210)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
| Original: |
J:82809 European Mouse Mutant Archive, Information obtained from the European Mouse Mutant Archive (EMMA). Unpublished. 2003-2013; |
| All: |
3 reference(s) |
|